Charles Blundell
Chief Technology Officer
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Charles Blundell serves as the Chief Technology Officer at C4X Discovery Holdings Plc in the UK. His research interests include the chemical modification of hyaluronan oligosaccharides, polymorph identification for flexible molecules, and the integration of single crystal X-ray diffraction with advanced powder data structure determination in early-stage drug discovery. His recent publications reflect a strong focus on the interactions of hyaluronan and hyaladherins, as well as innovative approaches to molecular characterization.
Articles (3)
Year:
2024
Year:
2024
Year:
2022
Collaborators (5)
Steven P. Brown
University of Warwick
Rebecca Dodd
The University of Manchester
Elena Kabova
Lecturer in Pharmaceutical Chemistry
University of Reading
Kenneth Shankland
University of Reading
Jan Johannes Enghild
Professor
Aarhus University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.